NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.23
0.01 (0.82%)
At close: Oct 09, 2025, 10:54 AM
0.82% (1D)
| Bid | 1.12 |
| Market Cap | 30.34M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.66M |
| EPS (ttm) | -0.36 |
| PE Ratio (ttm) | -3.42 |
| Forward PE | -5.75 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.53 |
| Volume | 89,055 |
| Avg. Volume (20D) | 647,485 |
| Open | 1.20 |
| Previous Close | 1.22 |
| Day's Range | 1.20 - 1.25 |
| 52-Week Range | 0.80 - 2.60 |
| Beta | 1.59 |
| Ex-Dividend Date | n/a |
About NRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+16.24%
NeuroSense Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
+2.8%
NRSN stock has given up its prior gain. NeuroSense Therapeutics shares were trading higher after the company announced a $500,000 private placement.
